应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01255 TATA健康
停牌 11-05 09:20:17
0.300
+0.000
0.00%
最高
0.300
最低
0.300
成交量
0.00
今开
0.300
昨收
0.300
日振幅
0.00%
总市值
7,285万
流通市值
7,285万
总股本
2.43亿
成交额
0.00
换手率
0.00%
流通股本
2.43亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
TATA健康：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌
新浪港股 · 10-15
TATA健康：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌
智通财经网 · 10-14
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌
TATA健康(01255)：进一步延迟刊发2023年年度业绩
智通财经 · 09-30
TATA健康(01255)：进一步延迟刊发2023年年度业绩
TATA健康(01255.HK)：接管人仍正在识别潜在买方
格隆汇 · 09-13
TATA健康(01255.HK)：接管人仍正在识别潜在买方
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
智通财经 · 09-13
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
智通财经 · 08-12
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
TATA健康(01255)延迟刊发2023年年度业绩 继续停牌
智通财经 · 07-31
TATA健康(01255)延迟刊发2023年年度业绩 继续停牌
【TATA健康(01255.HK)延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.HK)发布公告，该公司将进一步延迟刊发2023年年度业绩，原因为于本公告日期，公司仍在寻求额外营运资金以维持集团日常营运及现金流量， 且公司仍在按照审计师的要求从其附属公司收集和整理必要资料及文件以完成审核程序，故公司需要额外时间编制2023年年度业绩。
智通财经 · 07-31
【TATA健康(01255.HK)延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.HK)发布公告，该公司将进一步延迟刊发2023年年度业绩，原因为于本公告日期，公司仍在寻求额外营运资金以维持集团日常营运及现金流量， 且公司仍在按照审计师的要求从其附属公司收集和整理必要资料及文件以完成审核程序，故公司需要额外时间编制2023年年度业绩。
TATA健康：接管人仍正在识别潜在买方 且尚未达致销售
观点网 · 07-12
TATA健康：接管人仍正在识别潜在买方 且尚未达致销售
【TATA健康(01255.HK)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌】智通财经APP讯，TATA健康(01255.
智通财经 · 07-12
【TATA健康(01255.HK)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌】智通财经APP讯，TATA健康(01255.
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌
智通财经 · 07-12
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌
TATA健康(01255.HK)接复牌指引 续停牌
阿斯达克财经 · 07-02
TATA健康(01255.HK)接复牌指引 续停牌
【TATA健康(01255.HK)接获联交所复牌指引 继续停牌】智通财经APP讯，TATA健康(01255.HK)公布，公司于2024年6月27日接获联交所函件，当中为公司列明以下复牌指引：刊发上市规则规定的所有尚未刊发的财务业绩并处理任何审核修订;
智通财经 · 06-28
【TATA健康(01255.HK)接获联交所复牌指引 继续停牌】智通财经APP讯，TATA健康(01255.HK)公布，公司于2024年6月27日接获联交所函件，当中为公司列明以下复牌指引：刊发上市规则规定的所有尚未刊发的财务业绩并处理任何审核修订;
TATA健康(01255)接获联交所复牌指引 继续停牌
智通财经网 · 06-28
TATA健康(01255)接获联交所复牌指引 继续停牌
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
智通财经 · 06-14
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
【TATA健康(01255.HK)：延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.HK)发布公告，延迟刊发截至2023年12月31日止年度的年度业绩公告与寄发截至2023年12月31日止年度的年报。
智通财经 · 06-05
【TATA健康(01255.HK)：延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.HK)发布公告，延迟刊发截至2023年12月31日止年度的年度业绩公告与寄发截至2023年12月31日止年度的年报。
TATA健康(01255)：延迟刊发2023年年度业绩 继续停牌
智通财经 · 06-05
TATA健康(01255)：延迟刊发2023年年度业绩 继续停牌
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
智通财经 · 05-14
TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件
【TATA健康(01255.HK)：进一步延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.
智通财经 · 04-18
【TATA健康(01255.HK)：进一步延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.
TATA健康(01255)：进一步延迟刊发2023年年度业绩 继续停牌
智通财经 · 04-18
TATA健康(01255)：进一步延迟刊发2023年年度业绩 继续停牌
加载更多
公司概况
公司名称：
TATA健康
所属市场：
SEHK
上市日期：
--
主营业务：
TATA健康国际控股有限公司(原名：港大零售国际控股有限公司)是一家主要从事销售鞋类产品的投资控股公司。该公司通过四个分部运营业务。鞋类业务分部从事销售品牌名为Clarks、Josef Seibel、The Flexx和Petite Jolie的鞋类产品。金融服务业务分部提供证券的顾问服务，投资管理服务和企业融资的顾问服务。保健业务分部从事销售品牌名为AXS和Bio Lands及其他品牌的保健品以及Aptamil奶粉。线上医疗服务业务分部提供医疗服务，如医疗的顾问及咨询。
发行价格：
--
{"stockData":{"symbol":"01255","market":"HK","secType":"STK","nameCN":"TATA健康","latestPrice":0.3,"timestamp":1730769617123,"preClose":0.3,"halted":3,"volume":0,"delay":0,"floatShares":242845000,"shares":242845000,"eps":0.039584,"marketStatus":"停牌","marketStatusCode":0,"change":0,"latestTime":"11-05 09:20:17","open":0.3,"high":0.3,"low":0.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.094228,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730856600000},"adr":0,"adjPreClose":0.3,"openAndCloseTimeList":[[1730770200000,1730779200000],[1730782800000,1730793600000]],"volumeRatio":0.9166666632291668,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01255","defaultTab":"news","newsList":[{"id":"2475321375","title":"TATA健康：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2475321375","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475321375?lang=zh_cn&edition=full","pubTime":"2024-10-15 08:35","pubTimestamp":1728952539,"startTime":"0","endTime":"0","summary":"TATA健康（01255）发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。\n 此外，继续停牌。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-15/doc-incsqtkc1425815.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-15/doc-incsqtkc1425815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1114","BK1601","01255","BK1602"],"gpt_icon":0},{"id":"2475686033","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2475686033","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475686033?lang=zh_cn&edition=full","pubTime":"2024-10-14 19:49","pubTimestamp":1728906582,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。此外，继续停牌。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1193708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1601","BK1114","BK1602","01255"],"gpt_icon":0},{"id":"2471873084","title":"TATA健康(01255)：进一步延迟刊发2023年年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2471873084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471873084?lang=zh_cn&edition=full","pubTime":"2024-09-30 16:52","pubTimestamp":1727686352,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，延迟刊发截至2023年12月31日止年度的年度业绩公告与寄发截至2023年12月31日止年度的年报。基于目前进展，2023年年度业绩的预期寄发日期将自2024年9月底推迟至2024年11月底。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1114","BK1601","BK1602","01255"],"gpt_icon":0},{"id":"2467740921","title":"TATA健康(01255.HK)：接管人仍正在识别潜在买方","url":"https://stock-news.laohu8.com/highlight/detail?id=2467740921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467740921?lang=zh_cn&edition=full","pubTime":"2024-09-13 18:37","pubTimestamp":1726223827,"startTime":"0","endTime":"0","summary":"格隆汇9月13日丨TATA健康(01255.HK)公告，内容有关重启可能交易。公司谨此向公司股东及潜在投资者提供最新消息，经公司作出查询后，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409131843019562ccd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409131843019562ccd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01255","BK1114","BK1602","BK1601"],"gpt_icon":0},{"id":"2467742194","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2467742194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467742194?lang=zh_cn&edition=full","pubTime":"2024-09-13 18:21","pubTimestamp":1726222897,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，公司谨此向公司股东及潜在投资者提供最新消息，经公司作出查询后，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1114","BK1601","BK1602"],"gpt_icon":0},{"id":"2458676682","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2458676682","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458676682?lang=zh_cn&edition=full","pubTime":"2024-08-12 16:33","pubTimestamp":1723451606,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，公司谨此向公司股东及潜在投资者提供最新消息，经公司作出查询后，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1162918.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1601","BK1114","BK1602"],"gpt_icon":0},{"id":"2455902348","title":"TATA健康(01255)延迟刊发2023年年度业绩 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2455902348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455902348?lang=zh_cn&edition=full","pubTime":"2024-07-31 17:49","pubTimestamp":1722419345,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康 发布公告，该公司将进一步延迟刊发2023年年度业绩，原因为于本公告日期，公司仍在寻求额外营运资金以维持集团日常营运及现金流量， 且公司仍在按照审计师的要求从其附属公司收集和整理必要资料及文件以完成审核程序，故公司需要额外时间编制2023年年度业绩。由于2023年年度业绩可能延迟公布，预计2023年年报可能延迟寄发。此外，该公司股份继续停牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1601","BK1602","01255","BK1114"],"gpt_icon":0},{"id":"2455029509","title":"【TATA健康(01255.HK)延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.HK)发布公告，该公司将进一步延迟刊发2023年年度业绩，原因为于本公告日期，公司仍在寻求额外营运资金以维持集团日常营运及现金流量， 且公司仍在按照审计师的要求从其附属公司收集和整理必要资料及文件以完成审核程序，故公司需要额外时间编制2023年年度业绩。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455029509","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455029509?lang=zh_cn&edition=full","pubTime":"2024-07-31 17:49","pubTimestamp":1722419345,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01255","BK1602","BK1114","BK1601"],"gpt_icon":0},{"id":"2450302372","title":"TATA健康：接管人仍正在识别潜在买方 且尚未达致销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2450302372","media":"观点网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450302372?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:08","pubTimestamp":1720775280,"startTime":"0","endTime":"0","summary":"观点网讯：7月12日，TATA健康国际控股有限公司公告称，经本公司作出查询后，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121758139f3afc28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121758139f3afc28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1114","BK1601","01255","BK1602"],"gpt_icon":0},{"id":"2450305393","title":"【TATA健康(01255.HK)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌】智通财经APP讯，TATA健康(01255.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450305393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450305393?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:48","pubTimestamp":1720774102,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1602","BK1601","BK1114","01255"],"gpt_icon":0},{"id":"2450076303","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2450076303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450076303?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:48","pubTimestamp":1720774102,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，公司谨此向公司股东及潜在投资者提供最新消息，经公司作出查询后，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。此外，继续停牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1114","BK1602","BK1601","01255"],"gpt_icon":0},{"id":"2448037972","title":"TATA健康(01255.HK)接复牌指引 续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2448037972","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448037972?lang=zh_cn&edition=full","pubTime":"2024-07-02 10:36","pubTimestamp":1719887760,"startTime":"0","endTime":"0","summary":"TATA健康(01255.HK) 表示，接获联交所复牌指引，公司要刊发上市规则规定的所有尚未刊发的财务业绩并处理任何审核修订；证明公司遵守第13.24条；及向市场告知所有重要资料，以供股东及潜在投资者评估公司的状况。该股继续暂停买卖以待发布2023年年度业绩公告。(ha/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210712120647137_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210712120647137_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1360615/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01255","BK1114","BK1601","BK1602"],"gpt_icon":0},{"id":"2446507396","title":"【TATA健康(01255.HK)接获联交所复牌指引 继续停牌】智通财经APP讯，TATA健康(01255.HK)公布，公司于2024年6月27日接获联交所函件，当中为公司列明以下复牌指引：刊发上市规则规定的所有尚未刊发的财务业绩并处理任何审核修订;","url":"https://stock-news.laohu8.com/highlight/detail?id=2446507396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446507396?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:00","pubTimestamp":1719579624,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01255","BK1114","BK1601","BK1602"],"gpt_icon":0},{"id":"2446502072","title":"TATA健康(01255)接获联交所复牌指引 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2446502072","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446502072?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:00","pubTimestamp":1719579624,"startTime":"0","endTime":"0","summary":"TATA健康(01255)公布，公司于2024年6月27日接获联交所函件，当中为公...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1601","BK1114","01255","BK1602"],"gpt_icon":0},{"id":"2443625274","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2443625274","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443625274?lang=zh_cn&edition=full","pubTime":"2024-06-14 19:31","pubTimestamp":1718364684,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1135677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1114","BK1602","BK1601"],"gpt_icon":0},{"id":"2441228988","title":"【TATA健康(01255.HK)：延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.HK)发布公告，延迟刊发截至2023年12月31日止年度的年度业绩公告与寄发截至2023年12月31日止年度的年报。","url":"https://stock-news.laohu8.com/highlight/detail?id=2441228988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441228988?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:42","pubTimestamp":1717580527,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01255","BK1114","BK1602","BK1601"],"gpt_icon":0},{"id":"2441228609","title":"TATA健康(01255)：延迟刊发2023年年度业绩 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2441228609","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441228609?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:42","pubTimestamp":1717580527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，延迟刊发截至2023年12月31日止年度的年度业绩公告与寄发截至2023年12月31日止年度的年报。此外，继续停牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1131452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1114","BK1601","BK1602","01255"],"gpt_icon":0},{"id":"2435564308","title":"TATA健康(01255)：未就任何可能出售抵押股份订立任何确实交易文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2435564308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435564308?lang=zh_cn&edition=full","pubTime":"2024-05-14 16:43","pubTimestamp":1715676190,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，于本公告日期，接管人仍正在识别潜在买方，且尚未达致销售，亦未就任何可能出售抵押股份订立任何确实交易文件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1601","BK1114","BK1602"],"gpt_icon":0},{"id":"2428851331","title":"【TATA健康(01255.HK)：进一步延迟刊发2023年年度业绩 继续停牌】智通财经APP讯，TATA健康(01255.","url":"https://stock-news.laohu8.com/highlight/detail?id=2428851331","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428851331?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:59","pubTimestamp":1713452386,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01255","BK1114","BK1601","BK1602"],"gpt_icon":0},{"id":"2428330513","title":"TATA健康(01255)：进一步延迟刊发2023年年度业绩 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2428330513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428330513?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:59","pubTimestamp":1713452386,"startTime":"0","endTime":"0","summary":"智通财经APP讯，TATA健康(01255)发布公告，将进一步延迟刊发2023年年度业绩，原因为于本公告日期，公司仍在按核数师要求收集及核对其附属公司之必要资料及文件以完成审核过程，故公司需要额外时间编制2023年年度业绩。公司正与其附属公司及核数师密切沟通，收集一切所需资料及文件以尽快完成审核程序。然而，2023年年度业绩的预期刊发日期将需与核数师进一步商讨及厘定，并将适时刊发公告。公司股份继续停牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01255","BK1114","BK1601","BK1602"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.s-culture.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.2308},{"period":"ytd","weight":-0.0625}],"compareEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":-0.0761},{"period":"3month","weight":0.2446},{"period":"6month","weight":0.1332},{"period":"1year","weight":0.1692},{"period":"ytd","weight":0.2323}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"TATA健康国际控股有限公司(原名：港大零售国际控股有限公司)是一家主要从事销售鞋类产品的投资控股公司。该公司通过四个分部运营业务。鞋类业务分部从事销售品牌名为Clarks、Josef Seibel、The Flexx和Petite Jolie的鞋类产品。金融服务业务分部提供证券的顾问服务，投资管理服务和企业融资的顾问服务。保健业务分部从事销售品牌名为AXS和Bio Lands及其他品牌的保健品以及Aptamil奶粉。线上医疗服务业务分部提供医疗服务，如医疗的顾问及咨询。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.023959},{"month":2,"riseRate":0.5,"avgChangeRate":-0.019368},{"month":3,"riseRate":0.5,"avgChangeRate":0.243284},{"month":4,"riseRate":0.6,"avgChangeRate":0.048578},{"month":5,"riseRate":0.4,"avgChangeRate":0.015153},{"month":6,"riseRate":0.4,"avgChangeRate":-0.081021},{"month":7,"riseRate":0.2,"avgChangeRate":0.11493},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.053858},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.077045},{"month":10,"riseRate":0.454545,"avgChangeRate":0.035169},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.028513},{"month":12,"riseRate":0.363636,"avgChangeRate":0.018629}],"exchange":"SEHK","name":"TATA健康","nameEN":"TATA HEALTH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TATA健康(01255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TATA健康(01255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TATA健康,01255,TATA健康股票,TATA健康股票老虎,TATA健康股票老虎国际,TATA健康行情,TATA健康股票行情,TATA健康股价,TATA健康股市,TATA健康股票价格,TATA健康股票交易,TATA健康股票购买,TATA健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TATA健康(01255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TATA健康(01255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}